Infertility is a global health problem affecting millions of people of reproductive age. According to WHO data, infertility affects 48 million couples and 186 million individuals globally. Infertility is a male or female reproductive system disease characterized by the inability to achieve pregnancy.
Sperm separation on sorting is a means of choosing what type of sperm cell is to fertilize the egg cell. Sperm separation devices are medical and laboratory devices with a wide range of applications. To isolate and inseminate motile and healthy sperm for assisted reproductive technology (ART)-based procedures, sperm separation is required. ART methods include in-vitro fertilization (IVF), intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI), which require healthy and motile sperm insemination to increase fertilization success rates.
According to Arizton Advisory & intelligence, The global sperm separation devices market size was valued at USD 478.18 million in 2022 and is expected to reach USD 816.50 million by 2028, growing at a CAGR of 9.33%.
Read the Report Details: https://www.arizton.com/market-reports/sperm-separation-devices-market
Europe leads and dominates the global sperm separation devices market, accounting for 33.74% of the industry in 2022. Men’s sperm quality has declined in some European countries in recent years, increasing demand for fertility care. The use of sperm separation technologies for fertility care has expanded in the region. The region’s growing frequency of male infertility causes a considerable need for reproductive care, which promotes the application rate of fertility care services such as ART, where sperm-separating devices are commonly utilized. These reasons are propelling the region’s sperm separation devices market growth.
In 2022, the APAC sperm separation devices market was estimated to be worth USD 131 million. With the increasing acceptance of modern technology in reproductive health care services and increased knowledge about ART treatments, APAC is a fast-growing region in the worldwide sperm separation devices market. Infertility among males and females is increasing rapidly in the APAC region for a variety of reasons. Factors causing infertility in men include increased industrialization and accompanying pollution, a poor diet, and increased alcohol usage. These reasons boost demand for sperm separation technologies in fertility treatment.
The Latest Report by Arizton Provides Market Size, Share, & Trends Analysis Report By
- Method: Conventional and Advanced
- Product: Media and Equipment
- End-Users: Fertility Centers, Hospitals & Clinics, Labs & Cryopreserve Banks, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Download a Sample Report: https://www.arizton.com/request-sample/3747
The following factors are likely to contribute to the growth of the sperm separation devices market during the forecast period:
- Increasing Targeted Patient Population
- Rising Volume of ART & IVF Cycles
- Product Launched and Promotional Strategies in the Market
The report considers the present scenario of the sperm separation devices market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- Hamilton Thorne
- LensHook (Bonraybio)
- Menicon Co. Ltd.
- The Cooper Companies
Other Prominent Vendors
- Fujifilm Irvine Scientific
- Koek Biotechnology Bioengineering and Medical Services Industry and Trade Inc.
- Kitazato Corporation
- Lotus Bio
- NidaCon International Ab
- Promega Corporation
- SAR Healthline Pvt Ltd.
- Sperm Processor
MICROFLUIDIC SPERM SORTING
Microfluidics technology has emerged as a game changer in several disciplines of medicine and life sciences. Male infertility is one such area where microfluidic technology can improve sperm sample preparation and analysis. Microfluidic technology has been used to quantify sperm, analyze sperm quality, manipulate and isolate sperm, and then use the purified sperm population to treat male infertility.
An important sample preparation process in treating male-factor infertility is the selection of qualitatively and quantitatively sufficient sperm. Microfluidic system-based sperm sorting methods can increase motile sperm recovery from sperm, sperm recovery from extremely heterogeneous mixtures, and possibly minimize clinician skill requirements for the sperm purification process.
Microfluidics allows for the faster and gentler sorting of sperm cells, more closely emulating natural selection processes and avoiding some of the most harmful aspects of current sperm sorting techniques.
Microfluidic Sperm Sorting is a laboratory technique for distinguishing between healthy and motile sperm. The goal is to obtain sperm suitable for IVF or IUI. Sperm selection occurs naturally through an active passage through a membrane.
Male infertility is a very common problem. One method for addressing this issue is microfluidic sperm sorting. This method does not necessitate sperm pre-treatment (washing and centrifugation). As a result, sperm is protected from damage, and contamination is eliminated. This improves the success rate of the IVF cycle.
The Microfluidic Sperm Sorting chip is divided into two chambers.
- The first chamber is separated from the second chamber by a microporous membrane and has an inlet port for the sperm sample and a fluid channel.
- After 30 minutes of incubation at 37 degrees Celsius, the channel dimensions and membrane porosity are designed to sort and collect the best quality sperm.
For over 40 years, sperm cryopreservation has been used routinely to preserve fertility in men undergoing cancer treatment and to allow infertile couples to conceive.
However, several other clinical applications for sperm freezing have emerged in recent years.
Freezing sperm prior to treatment provides patients with “fertility insurance,” allowing them to father their own children via intrauterine insemination or in vitro fertilization techniques such as intracytoplasmic sperm injection (ICSI).
Sperm cryopreservation is required in donor-insemination programs. Frozen sperm allows donors to be screened for infectious diseases such as HIV and hepatitis B before being released for insemination. To eliminate the need for additional biopsies or aspirations, sperm from azoospermic individuals who have undergone testicular sperm extraction or percutaneous epididymal sperm aspiration (PESA) is frequently stored via cryopreservation.
Cryopreservation is a substantially better choice for fertility preservation (male sperm preservation) in a patient with gonadal failure for any reason or condition, as well as for males who desire to store their sperm/germ cells for future use. Methods to freeze sperm have been available for some time. Nonetheless, it has increased in recent years as the male population’s awareness of infertility care has grown.
Sperm cryopreservation has become a standard procedure in assisted reproductive technologies and is increasingly used in clinical procedures. It can potentially boost IVF cycle success rates, increasing demand for sperm cryopreservation. It is anticipated to fuel the increased need for sperm-separating technologies and media. Sperm cryopreservation/cryobanking becomes a major alternative for breeding in captivity in order to store and preserve genetics.
Check out Other Related Reports:
Fertility Test Market – Global Outlook & Forecast 2022-2027
U.S. Assisted Reproductive Technology Market – Industry Outlook & Forecast 2022-2027
Fertility Supplements Market – Global Outlook & Forecast 2022-2027
U.S. In-Vitro Fertilization (IVF) Market – Industry Outlook and Forecast 2021-2026
Arizton’s Expertise in Healthcare Industry:
Arizton offers both syndicate and custom market intelligence & competitive intelligence solutions across MedTech, pharmaceuticals, and life sciences & biotechnology markets within the healthcare industry. Arizton’s healthcare vertical provide un-biased research and evidence-based analysis to support business decisions and end-to-end comprehensive solutions to its customers covering all dimensions of the healthcare value chain. We track various devices (equipment, implants, and hospital supplies) and drugs (patented, generic, & OTC) across North America, Europe, APAC, Latin America, and the Middle East & Africa regions. The healthcare reports provide historic and forecast data for 20+ key countries worldwide. We track product approvals/launches, M&A activities, and collaboration/partnership activities among pharma/biotech, medical device, and life sciences companies. Our pharmaceutical portfolio tracks 15+ therapy areas with a major focus on immunology, oncology, rare & genetic diseases, dermatology, and metabolic diseases. Our medical devices and life sciences portfolio covers in-vitro diagnostics, healthcare IT, patient monitoring, cardiovascular devices, medical imaging, personal protective equipment, clinical laboratory services, CMO/CDMO services.
Exclusive reports on Healthcare: https://www.arizton.com/market-reports/category/healthcare-lifesciences
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
+1 302 469 0707
Contact Us: https://www.arizton.com/contact-us